First Pacific Advisors, LP has opened a new $175.2M position in $BDX, per a new SEC 13F filing. This disclosure reflects the funds' holdings for the 09-30-2025 report period. You can see the fund's full portfolio on Quiver Quantitative, and also track the largest institutional owners of $BDX.
$BDX Hedge Fund Activity
We have seen 735 institutional investors add shares of $BDX stock to their portfolio, and 853 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MORGAN STANLEY removed 4,598,284 shares (-53.5%) from their portfolio in Q2 2025, for an estimated $792,054,419
- FRANKLIN RESOURCES INC added 4,051,718 shares (+150.9%) to their portfolio in Q3 2025, for an estimated $758,360,058
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 3,603,168 shares (+28.7%) to their portfolio in Q2 2025, for an estimated $620,645,688
- GQG PARTNERS LLC removed 3,011,583 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $518,745,171
- PRICE T ROWE ASSOCIATES INC /MD/ removed 2,430,362 shares (-21.5%) from their portfolio in Q2 2025, for an estimated $418,629,854
- HARRIS ASSOCIATES L P added 1,625,391 shares (+125.8%) to their portfolio in Q2 2025, for an estimated $279,973,599
- AMERIPRISE FINANCIAL INC removed 1,456,702 shares (-80.9%) from their portfolio in Q2 2025, for an estimated $250,916,919
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$BDX Insider Trading Activity
$BDX insiders have traded $BDX stock on the open market 10 times in the past 6 months. Of those trades, 1 have been purchases and 9 have been sales.
Here’s a breakdown of recent trading of $BDX stock by insiders over the last 6 months:
- GREGORY HAYES purchased 5,250 shares for an estimated $1,005,742
- CLAIRE FRASER has made 0 purchases and 2 sales selling 1,780 shares for an estimated $337,892.
- MICHAEL DAVID GARRISON (EVP & President, Medical) has made 0 purchases and 2 sales selling 1,185 shares for an estimated $213,644.
- DAVID SHAN (EVP and Chief ISC Officer) sold 1,166 shares for an estimated $199,607
- BERTRAM L SCOTT sold 217 shares for an estimated $38,317
- MICHAEL FELD (EVP & President, Life Sciences) has made 0 purchases and 3 sales selling 172 shares for an estimated $32,387.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$BDX Government Contracts
We have seen $76,180,070 of award payments to $BDX over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- INFUSION PUMPS MULTIPLE-AWARD IDIQ VISN 10 ORDER: $5,252,124
- INFUSION PUMPS: $5,057,297
- 8511358199!PHARMACY AUTOMATION MAINTENAN: $4,072,311
- FLEET REPLACEMENT INFUSION PUMPS: $2,996,961
- INFUSION PUMPS IN SUPPORT OF VA PUGET SOUND HEALTHCARE SYSTEM, SEATTLE WA: $2,390,729
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
$BDX Congressional Stock Trading
Members of Congress have traded $BDX stock 3 times in the past 6 months. Of those trades, 2 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $BDX stock by members of Congress over the last 6 months:
- REPRESENTATIVE LISA C. MCCLAIN has traded it 2 times. They made 1 purchase worth up to $15,000 on 06/17 and 1 sale worth up to $15,000 on 06/24.
- REPRESENTATIVE ROBERT BRESNAHAN purchased up to $15,000 on 05/15.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$BDX Analyst Ratings
Wall Street analysts have issued reports on $BDX in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Barclays issued a "Overweight" rating on 06/03/2025
To track analyst ratings and price targets for $BDX, check out Quiver Quantitative's $BDX forecast page.
$BDX Price Targets
Multiple analysts have issued price targets for $BDX recently. We have seen 6 analysts offer price targets for $BDX in the last 6 months, with a median target of $193.5.
Here are some recent targets:
- Shagun Singh from RBC Capital set a target price of $202.0 on 11/07/2025
- Jason Bednar from Piper Sandler set a target price of $190.0 on 11/07/2025
- Patrick Wood from Morgan Stanley set a target price of $197.0 on 08/11/2025
- Lawrence Biegelsen from Wells Fargo set a target price of $184.0 on 08/08/2025
- Matt Miksic from Barclays set a target price of $241.0 on 06/03/2025
- Joanna Wiensch from Citigroup set a target price of $185.0 on 05/22/2025
Note that there may be inaccuracies in these estimates due to filing errors by the funds, parsing errors by us, or other anomalies.
Check out Quiver Quantitative's $BDX ticker page for more data.
